
Shoulder & Elbow
No role for ISBPB plus local liposomal bupivacaine in shoulder arthroplasty
This report has been verified
by one or more authors of the
original publication.
J Bone Joint Surg Am. 2018 Aug 15;100(16):1373-1378. doi: 10.2106/JBJS.17.01416
78 patients scheduled for total shoulder arthroplasty with an interscalene block for regional anesthesia were randomized to the procedure with or without the addition of intraoperative local infiltration of liposomal bupivacaine. Patients were assessed for narcotic consumption over the first 24 hours after surgery, and for pain scores over the first 72 hours after surgery. Narcotic consumption was significantly higher over the first 24 hours among patients administered liposomal bupivacaine compared to patients who were not. No significant differences between groups were noted in pain scores at any time point up to 72 hours postoperatively.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.